Back
Medpace Holdings Vs. Cellectar Biosciences Industry Stock Comparison
Sell
33
MEDP
Medpace Holdings
Last Price:
352.75
Seasonality Move:
9.71%
Sell
47
CLRB
Cellectar Biosciences
Last Price:
2.11
Seasonality Move:
-15.64%
Sell
33
Medpace Holdings (MEDP)
is a Sell
Is Medpace Holdings a Buy, Sell or Hold?
- The current Medpace Holdings [MEDP] share price is $351.67. The Score for MEDP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- MEDP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $2.13. The Score for CLRB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MEDP Stock Price Chart
What is Medpace Holdings's stock price today?
-
The Medpace Holdings share price today is $351.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEDP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $2.13
The current trend is relatively stagnant and CLRB is experiencing slight selling pressure.
MEDP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.17 | Sell |
| Relative Strength Index (14 RSI): | 43.24 | Sell |
| Chaikin Money Flow: | 285943 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (346.65 - 389.81) | Sell |
| Bollinger Bands (100): | (368.69 - 414.59) | Sell |
CLRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 48.43 | Sell |
| Chaikin Money Flow: | -40586 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.01 - 2.17) | Buy |
| Bollinger Bands (100): | (2.14 - 3.12) | Sell |
MEDP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 341.13 | Buy |
| 20-day SMA: | 364.53 | Sell |
| 50-day SMA: | 385.24 | Sell |
| 200-day SMA: | 367.99 | Sell |
| 8-day EMA: | 345.79 | Buy |
| 20-day EMA: | 358.37 | Sell |
| 50-day EMA: | 375.47 | Sell |
| 200-day EMA: | 360.44 | Sell |
CLRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Buy |
| 20-day SMA: | 2.13 | Buy |
| 50-day SMA: | 2.22 | Sell |
| 200-day SMA: | 2.99 | Sell |
| 8-day EMA: | 2.12 | Buy |
| 20-day EMA: | 2.13 | Buy |
| 50-day EMA: | 2.27 | Sell |
| 200-day EMA: | 2.69 | Sell |
Medpace Holdings Earnings Growth & MEDP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.68 per share, an increase next quarter of $0.42 per share, an increase this year of $2.71 per share, and an increase next year of $1.59 per share.
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.
Medpace Holdings Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cellectar Biosciences Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||